OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells is a paramount challenge with the Recombinant Antibody biopharmaceutical industry. A variety of strategies can be employed maximize antibody titer, including process parameter optimization, media optimization, and adoption of perfusion systems. Fine-tunin